Psoriasiform drug eruption induced by anti-tuberculosis medication: potential role of plasma-cytoid dendritic cells.
Jae-Jeong
JJ
Park
Yoo Duk
YD
Choi
Jee-Bum
JB
Lee
Seong-Jin
SJ
Kim
Seung-Chul
SC
Lee
Young Ho
YH
Won
Sook Jung
SJ
Yun
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000368:Aged; D000995:Antitubercular Agents / Q000009:adverse effects*; D001706:Biopsy; D003713:Dendritic Cells / Q000187:drug effects* / Q000276:immunology; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D004890:Erythema / Q000139:chemically induced; D006633:Histamine Antagonists / Q000008:administration & dosage; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D011537:Pruritus / Q000139:chemically induced; D011565:Psoriasis / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D013256:Steroids / Q000008:administration & dosage; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D006633:Histamine Antagonists; D013256:Steroids